$52.2B
$16.1 Million
0.01% of portfolio
80
Q2 2025
Reduced 23.81%
$12.6B
$23 Million
0.01% of portfolio
2,581
Q1 2025
Reduced 24.77%
Anglo Amern PLC Funsponsored Adr 1 Adr Reps 0.5 Ord Shs
-
$13 Million
0.01% of portfolio
-
Q2 2025
New
$3.32B
$12.6 Million
0.01% of portfolio
650
Q2 2025
Reduced 59.38%
$0
$18.6 Million
0.01% of portfolio
156
Q4 2024
Reduced 96.5%
$34.3B
$9.27 Million
0.01% of portfolio
90
Q1 2025
Reduced 10.0%
$4.91B
$9.9 Million
0.01% of portfolio
2,000
Q3 2024
Added 149.0%
$477B
$10.3 Million
0.01% of portfolio
65
Q2 2025
New
$38.3B
$19.3 Million
0.01% of portfolio
195
Q1 2025
Added 8.33%
$0
$19.6 Million
0.01% of portfolio
148
Q3 2024
New
$0
$14.2 Million
0.01% of portfolio
57,969
Q2 2025
New
$97.8B
$8.8 Million
0.01% of portfolio
53
Q2 2025
Reduced 97.59%
$19.6B
$22.9 Million
0.01% of portfolio
200
Q3 2024
New
$6.56B
$12.4 Million
0.01% of portfolio
-
Q2 2025
New
-
$16.7 Million
0.01% of portfolio
-
Q2 2025
New
$39.4B
$21.2 Million
0.01% of portfolio
505
Q2 2025
Added 10,000.0%
$0
$21.9 Million
0.01% of portfolio
480
Q3 2024
New
$161B
$11.7 Million
0.01% of portfolio
59
Q3 2024
New
$25.7B
$16.8 Million
0.01% of portfolio
122
Q3 2024
New
Olympus Corp Funsponsored Adr 1 Adr Reps 1 Ord Shs
-
$9.42 Million
0.01% of portfolio
-
Q2 2025
New
$25B
$19.7 Million
0.01% of portfolio
600
Q3 2024
New
$0
$8.13 Million
0.01% of portfolio
91
Q3 2024
New
$0
$8.57 Million
0.01% of portfolio
200
Q1 2025
Reduced 73.33%
$21.7B
$10.6 Million
0.01% of portfolio
84
Q3 2024
Added 1,297.62%
$0
$10.5 Million
0.01% of portfolio
320
Q1 2025
Reduced 96.13%
$31B
$10.8 Million
0.01% of portfolio
185
Q3 2024
New
$26.8B
$13.7 Million
0.01% of portfolio
7
Q2 2025
Added 133.33%
$115B
$13.9 Million
0.01% of portfolio
238
Q4 2024
Reduced 67.75%
$19.7B
$10.2 Million
0.01% of portfolio
175
Q2 2025
Reduced 71.54%
$41.7B
$997,000
0.0% of portfolio
3
Q3 2024
New
$55.3B
$7.53 Million
0.0% of portfolio
175
Q2 2025
New
$0
$1.19 Million
0.0% of portfolio
15
Q3 2024
Added 366.67%
Gsk PLC Adr Fsponsored Adr 1 Adr Reps 2 Ord Shs
-
$5.15 Million
0.0% of portfolio
-
Q3 2024
New
$1.55B
$7.47 Million
0.0% of portfolio
115
Q3 2024
New
$270B
$1.6 Million
0.0% of portfolio
5
Q1 2025
New
$1.8B
$436,000
0.0% of portfolio
45
Q3 2024
New
-
$1.92 Million
0.0% of portfolio
-
Q3 2024
New
$1.22B
$15,000
0.0% of portfolio
1
Q3 2024
New
$495M
$1.2 Million
0.0% of portfolio
128
Q3 2024
New
$17.4B
$965,000
0.0% of portfolio
20
Q2 2025
New
$0
$6.12 Million
0.0% of portfolio
102
Q3 2024
New
$0
$1.66 Million
0.0% of portfolio
20
Q1 2025
Reduced 90.0%
$40.4B
$788,000
0.0% of portfolio
5
Q3 2024
New
$5.6B
$4.77 Million
0.0% of portfolio
65
Q3 2024
New
$49.4B
$4.74 Million
0.0% of portfolio
414
Q2 2025
Reduced 30.65%
$0
$1.22 Million
0.0% of portfolio
25
Q2 2025
Reduced 98.6%
$72B
$1.33 Million
0.0% of portfolio
5
Q1 2025
New
$10.5B
$4.16 Million
0.0% of portfolio
170
Q3 2024
New
$108B
$3.56 Million
0.0% of portfolio
8
Q3 2024
New
$114B
$5.86 Million
0.0% of portfolio
100
Q3 2024
New